Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI

Lignende værker

• The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
  af: Fu-Tsai Chung, et al.
  Udgivet: (2015-01-01)
• The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
  af: Chung, Fu-Tsai, et al.
  Udgivet: (2015)
• EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials
  af: Wu, Jing-Xun, et al.
  Udgivet: (2018)
• Predictive Factors for Switched EGFR-TKI Retreatment in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
  af: Kwon, Byoung Soo, et al.
  Udgivet: (2017)
• First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  af: Wu, Qiang, et al.
  Udgivet: (2021)